UroGen Pharma Ltd. Ordinary Shares
URGN Real Time Price USDRecent trades of URGN by members of U.S. Congress
|
Name
|
Type
|
Shares
|
Price
|
Shares Held
|
Date
|
Reported
|
|---|
|
Investor
|
Shares
|
Change in Shares
|
Market Value
|
Date
|
Reported
|
|---|
|
Investor
|
Type
|
Shares
|
Change in Shares
|
Market Value
|
Date
|
Reported
|
|---|
Recently reported changes by institutional investors
Quarterly net insider trading by URGN's directors and management
Government lobbying spending instances
-
$30,000 Oct 21, 2024 Issue: Health Issues
-
$30,000 Apr 22, 2024 Issue: Health Issues
-
$30,000 Jan 22, 2024 Issue: Health Issues
-
$30,000 Oct 20, 2023 Issue: Health Issues
-
$30,000 Jul 20, 2023 Issue: Health Issues
-
$30,000 Apr 20, 2023 Issue: Health Issues
-
$60,000 Jan 20, 2023 Issue: Health Issues
-
$60,000 Oct 20, 2022 Issue: Health Issues
-
$20,000 Jul 20, 2022 Issue: Health Issues
-
$40,000 Jul 18, 2022 Issue: Health Issues
-
$40,000 Apr 15, 2022 Issue: Health Issues
-
$40,000 Jan 15, 2022 Issue: Health Issues
-
$40,000 Oct 18, 2021 Issue: Health Issues
-
$40,000 Jul 16, 2021 Issue: Health Issues
-
$40,000 Apr 17, 2021 Issue: Health Issues
-
$40,000 Jan 15, 2021 Issue: Health Issues
-
$40,000 Oct 19, 2020 Issue: Health Issues
-
$40,000 Jul 12, 2020 Issue: Health Issues
-
$40,000 Apr 20, 2020 Issue: Health Issues
Estimated quarterly lobbying spending
New patents grants
Federal grants, loans, and purchases
- $98,856 2024-04-01 00:00:00 Agency: Department of Veterans Affairs
- $98,856 2024-03-21 00:00:00 Agency: Department of Veterans Affairs
- $97,430 2023-06-22 00:00:00 Agency: Department of Veterans Affairs
- $194,860 2023-06-09 00:00:00 Agency: Department of Veterans Affairs
- $97,430 2023-06-07 00:00:00 Agency: Department of Veterans Affairs
- $0 2021-02-26 00:00:00 Agency: DEPARTMENT OF VETERANS AFFAIRS (VA)
- $0 2020-12-16 00:00:00 Agency: DEPARTMENT OF VETERANS AFFAIRS (VA)
- $0 2020-10-01 Agency: DEPARTMENT OF VETERANS AFFAIRS (VA)
Estimated quarterly amount awarded from public contracts
Number of mentions of URGN in WallStreetBets Daily Discussion
Recent insights relating to URGN
Recent picks made for URGN stock on CNBC
ETFs with the largest estimated holdings in URGN
The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.
The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.Sign Up to view URGN Smart Score
See concise summaries of analyst reports, presenting both bullish and bearish arguments for a stock.
Example:
The Bulls Say summary highlights positive aspects of the stock.
The Bears Say summary points out potential risks and negative aspects of the stock.